Abstract:Objective We have previously shown that genetic deletion of the transcription factor E2F1 increases the expression of vascular endothelial growth factor (VEGF) and enhances blood flow recovery in the ischaemic limb (Qin et al, PNAS 2006). However, the physiological significance of this regulation in ischaemic heart disease and the molecular mechanisms of E2F1-mediated VEGF regulation are still unknown. The purpose of this study is to understand the role of E2F1 in cardiac neovascularization following ischaemic injury. Methods and results Myocardial infarction (MI) was induced by surgical ligation of the Left Anterior Descending (LAD) coronary artery in wild-type (WT) and E2F1–/– mice. At day 5 after surgery, angiogenic factors at the infarct border zone were analysed by qRT-PCR and Western blotting. At day 28, the vascular density and infarct size were evaluated histologically. VEGF mRNA and protein levels were significantly higher in E2F1–/– than in WT mice (p<0.01, n=5). E2F1–/– mice displayed a greater vessel density in the infarct border area (p<0.01, n=5) and a smaller infarct size (p<0.01, n=15). In vitro, hypoxia treatment (0.5% O2 for 24 h) increased VEGF mRNA expression to a higher level in E2F1–/– cardiac fibroblasts than in WT control cells (p<0.01, n=3). Overexpression of E2F1 suppressed the hypoxia-induced VEGF promoter activity in WT cells, however, (del) but not in p53–/– cells, suggesting that p53 is required for E2F1 to suppress VEGF transcription. Hypoxia treatment (0.5% O2) for 24 h dramatically increased the level of both E2F1 and p53 proteins; overexpression of E2F1 further enhanced the hypoxia-induced accumulation of p53. To understand whether E2F1 regulates p53 protein stability, we treated WT and E2F1–/– cardiac fibroblasts with hypoxia for 6h, pulsed the cells with cyclohexamide (40 mg/ml) and chased p53 degradation. The p53 protein level declined gradually in WT cells (half-life: ∼4 h), but, significantly faster in E2F1–/– cells (half-life: ∼1h) (p<0.01 at 1, 2, and 4 h, n=4). Interestingly, addition of Lactacystin significantly delayed the rates of p53 degradation in both WT and E2F1–/– cells and eliminated the difference between the two groups of cells, suggesting that under hypoxia, E2F1 promotes p53 accumulation by attenuating its ubiquitin-proteasomal degradation. Furthermore, co-immunoprecipitation (co-IP) experiments indicated that hypoxia treatment induced physical associations between E2F1 and p53. In the E2F1–/– fibroblasts transiently transfected with HA-tagged E2F1 or E2F1 truncation mutants, p53 co-precipitated with the ectopically expressed WT E2F1 and the E2F1 mutants with deletions in the transactivaton domain and/or DP-dimerisation domain, but not with the E2F1 mutant with a deletion in the N-terminus (amino acids 1−109), suggesting that the N-terminal region is essential for E2F1 to interact with p53. Conclusions The E2F1 stabilises p53 protein, thereby suppressing VEGF expression and new vessel formation in the ischaemic heart. Targeting E2F1:p53 interaction (eg, by E2F1 N-terminal peptide) may protect heart from ischaemic injury.

Ras Homolog Gene Family, Member A Promotes P53 Degradation and Vascular Endothelial Growth Factor-Dependent Angiogenesis Through an Interaction with Murine Double Minute 2 under Hypoxic Conditions

Role of Activated Rac1/Cdc42 in Mediating Endothelial Cell Proliferation and Tumor Angiogenesis in Breast Cancer

Role Of Rac1 And Cdc42 In Hypoxia Induced P53 And Von Hippel-Lindau Suppression And Hif1 Alpha Activation

The Rho Gtpase Rhoe Is A P53-Regulated Candidate Tumor Suppressor In Cancer Cells

RPL23 Links Oncogenic RAS Signaling to P53-Mediated Tumor Suppression

MDM2 Promotes Cancer Cell Survival Through Regulating the Expression of HIF-1α and Pvhl in Retinoblastoma

CDK5RAP3 Inhibition by Hypoxia Activates P38MAPK to Facilitate Angiogenesis

p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression

The Effect of RhoA and Proteasome Inhibitor MG132 on Angiogenesis in Tumors

A positive feedback loop between miR-574-3p and HIF-1α in promoting angiogenesis under hypoxia

Effect of Rho GTPases on Tumor Angiogenesis-related Molecules

Breast Cancer Cells-Derived Von Willebrand Factor Promotes VEGF-A-related Angiogenesis Through PI3K/Akt-miR-205-5p Signaling Pathway

Rhoc Is Essential For Angiogenesis Induced By Hepatocellular Carcinoma Cells Via Regulation Of Endothelial Cell Organization

E0049 E2F1 Stabilises P53 to Suppress VEGF Expression and Neovascularization in the Ischaemic Myocardium

Activation of RhoA/ROCK2 signaling by hypoxia-inducible factor 1α in promoting tumor growth and metastasis in human colon cancer

PTP1B Controls Non-Mitochondrial Oxygen Consumption by Regulating RNF213 to Promote Tumour Survival During Hypoxia.

The role of MDM2 in angiogenesis: implications for endothelial tip cell formation

The regulatory role of colorectal adenocarcinoma hypoxia-inducible factor-l α in the expression of n-myc down-stream regulative gene 1

miR-34a and IRE1A/XBP-1(S) Form a Double-Negative Feedback Loop to Regulate Hypoxia-Induced EMT, Metastasis, Chemo-Resistance and Autophagy

Tumor-Derived Microrna-494 Promotes Angiogenesis in Non-Small Cell Lung Cancer

RGS5 maintaining vascular homeostasis is altered by the tumor microenvironment